Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytoprotection”

14 trials

Showing 14 of 14 results

Testing effectiveness (Phase 2)WithdrawnNCT00556387
What this trial is testing

Efficacy of Ketamine in Children With Severe Brain Injury for Brain Cell Protection

Who this might be right for
Traumatic Brain Injury
University of Arkansas
Testing effectiveness (Phase 2)WithdrawnNCT04845191
What this trial is testing

COVID-19 Subcutaneously and Orally Administered Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines

Who this might be right for
Covid19
ImmunityBio, Inc.
Not applicableStudy completedNCT00423553
What this trial is testing

Collection of Heart Tissue Sample During Open Heart Surgery

Who this might be right for
Ischemia
National Heart, Lung, and Blood Institute (NHLBI)
Early research (Phase 1)Study completedNCT00571298
What this trial is testing

Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Brigham and Women's Hospital 141
Testing effectiveness (Phase 2)Looking for participantsNCT06440707
What this trial is testing

Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
University of California, Los Angeles 120
Testing effectiveness (Phase 2)Study completedNCT00623142
What this trial is testing

The Protective Effects Of Treatment With Hyperbaric Oxygen Prior To Bypass Heart Surgery

Who this might be right for
Myocardial Reperfusion InjuryCytoprotection
Hull University Teaching Hospitals NHS Trust 81
Early research (Phase 1)Study completedNCT00482846
What this trial is testing

Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma

Who this might be right for
MucositisMultiple Myeloma
Barbara Ann Karmanos Cancer Institute 38
Testing effectiveness (Phase 2)WithdrawnNCT04843722
What this trial is testing

COVID-19 Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines

Who this might be right for
Covid19
ImmunityBio, Inc.
Large-scale testing (Phase 3)UnknownNCT05885919
What this trial is testing

Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke

Who this might be right for
Ischemic Stroke, AcuteTreatment Outcome
Xiangya Hospital of Central South University 212
Not applicableActive Not RecruitingNCT07174882
What this trial is testing

Evaluation of the Clinical Course of NERD and Assessment of the Esophageal Mucosa Resistance

Who this might be right for
Non-Erosive Gastro-Esophageal Reflux DiseaseGastroesophageal Reflux Disease (GERD)
I.M. Sechenov First Moscow State Medical University 60
Testing effectiveness (Phase 2)Study completedNCT00003068
What this trial is testing

High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/Organ
University of Arizona 30
Testing effectiveness (Phase 2)Study completedNCT06967025
What this trial is testing

Ischemic Postconditioning in Acute Stroke Patients Receiving Endovascular Thrombectomy

Who this might be right for
Stroke AcuteCytoprotectionIschemic Conditioning
Tianjin Huanhu Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00003425
What this trial is testing

Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect

Who this might be right for
Breast CancerLeukemiaLymphoma+4 more
University of Kentucky 25
Testing effectiveness (Phase 2)Study completedNCT00006105
What this trial is testing

Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer

Who this might be right for
Bladder CancerDrug/Agent Toxicity by Tissue/Organ
University of Chicago 37

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation